Nutex Health Inc. (NUTX): Nasdaq/NYSE listing notice — Nutex Health receives Nasdaq notice for bid price below $1.00; 180 days to regain compliance

Nutex Health Inc.

Received Nasdaq deficiency letter on May 22, 2023; bid price below $1.00 for 30 consecutive business days.
Compliance period ends November 20, 2023; need $1.00 close for 10 consecutive business days.
No immediate delisting; company considering options including reverse stock split.
If not compliant by Nov 20, may qualify for additional 180-day period subject to other standards.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Nutex Health Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

May 22, 2023, Nutex Health Inc. (the “Company”) received a letter (the “Nasdaq Staff Deficiency Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, for the last thirty (30) consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per share requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided an initial period of 180 calendar days, or until November 20, 2023, t

View on SEC.gov

Browse all listing & compliance notices →

Nutex Health Inc. filing history →

Source: SEC EDGAR

accession 0001558370-23-010549

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.